APG-115 was also more potent than MDM2 inhibitor RG-7388 in both TP53wt (MOLM-13 and MV-4-11) and TP53mut (SKM-1) AML cell lines (Supplementary Table 1). Here, MDM2 is linked to acute myeloid leukemia.